Stay updated on Incyte Press Releases
Sign up to get notified when there's something new on the Incyte Press Releases page.
Latest updates to the Incyte Press Releases page
- ChecktodayChange DetectedNew press releases were added to the listing (Nov 3, 2025; Oct 28–30, 2025). Older releases were removed from the listing.SummaryDifference6%
- Check8 days agoChange DetectedTwo new press releases were added (October 27, 2025 and October 25, 2025). The listing count changed from 46 to 48 and an older September 3, 2025 release was removed.SummaryDifference6%
- Check15 days agoChange Detected- Replaced leadership news item with a scientific/clinical trial announcement for Incyte. - The page now prominently features Phase 1 results for a bispecific antibody and a KRAS G12D inhibitor, shifting focus from executive appointment to drug development milestones.SummaryDifference20%
- Check22 days agoChange DetectedNew items about ESMO presentation and Q3 results added; older items about investor conferences and CFO departure removed.SummaryDifference100%
- Check36 days agoChange DetectedNew leadership appointment announced and more recent dates added; older quarterly results and conference data removed.SummaryDifference100%
- Check44 days agoChange DetectedAdds recent news items and updated page navigation; removes an older quarterly results item and an older listing count. The focus shifts to new clinical news and current dates.SummaryDifference100%
Stay in the know with updates to Incyte Press Releases
Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.